AJP - Heart AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 280: H2623-H2630, 2001;
0363-6135/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kögler, H.
Right arrow Articles by Marbán, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kögler, H.
Right arrow Articles by Marbán, E.
Vol. 280, Issue 6, H2623-H2630, June 2001

Maintained contractile reserve in a transgenic mouse model of myocardial stunning

Harald Kögler1,3,4, David G. Soergel2,3, Anne M. Murphy2,3, and Eduardo Marbán1,3

1 Departments of Medicine and 2 Pediatrics and 3 Institute of Molecular Cardiobiology, Johns Hopkins University, Baltimore, Maryland 21205; and 4 Department of Cardiology and Pneumology, Georg-August-University, 37075 Göttingen, Germany


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Cardiac excitation-contraction (E-C) coupling is impaired at the myofilament level in the reversible postischemic dysfunction known as "stunned" myocardium. We characterized tension development and calcium cycling in intact isolated trabeculae from transgenic (TG) mice expressing the major proteolytic degradation fragment of troponin I (TnI) found in stunned myocardium (TnI1-193) and determined the ATPase activity of myofibrils extracted from TG and non-TG mouse hearts. The phenotype of these mice at baseline recapitulates that of stunning. Here, we address the question of whether contractile reserve is preserved in these mice, as it is in genuine stunned myocardium. During twitch contractions, calcium cycling was normal, whereas tension was greatly reduced, compared with non-TG controls. A decrease in maximum Ca2+-activated tension and Ca2+ desensitization of the myofilaments accounted for this contractile dysfunction. The decrease in maximum tension was paralleled by an equivalent decrease in maximum Ca2+-activated myofibrillar ATPase activity. Exposure to high calcium or isoproterenol recruited a sizable contractile reserve in TG muscles, which was proportionately similar to that in control muscles but scaled downward in amplitude. These results suggest that calcium regulatory pathways and beta -adrenergic signal transduction remain intact in isolated trabeculae from stunned TG mice, further recapitulating key features of genuine stunned myocardium.

cardiac excitation-contraction coupling; signal transduction; calcium ion sensitivity


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

REPERFUSION AFTER BRIEF MYOCARDIAL ISCHEMIA leaves behind a sustained contractile dysfunction despite the absence of irreversible structural damage and despite complete restoration of coronary flow (5). This condition, which has been termed "stunned myocardium" (7), may persist for hours to up to several days but is, eventually, fully reversible. With the development of methods aimed at achieving prompt reperfusion in patients with acute myocardial ischemia, stunned myocardium is now recognized to be of considerable clinical relevance (4).

Intracellular Ca2+ homeostasis in stunned myocardium appears to be unimpaired (19). Depressed contractile function despite normal Ca2+ cycling is indicative of a reduced Ca2+ responsiveness of contraction, which was, indeed, shown in isolated intact trabeculae from ischemic-reperfused rat hearts (13). This pinpoints the critical lesion to the myofilaments, which translate the intracellular Ca2+ signal into force development during the distal steps of excitation-contraction (E-C) coupling. On the basis of reports showing that the activity of the Ca2+-dependent proteolytic enzyme calpain is enhanced in postischemic-reperfused myocardium (30, 31), Gao et al. (13) used an immunoblot analysis to probe myofibrillar homogenates from rat stunned myocardium for proteolysis products of a variety of myofilament proteins. The thin-filament regulatory protein troponin I (TnI) uniquely displayed a low-molecular-weight band in addition to the parent protein, indicating specific partial proteolytic degradation. The primary TnI degradation product was subsequently identified as TnI1-193, which lacks the 17 COOH-terminal residues of full-length cardiac TnI (22).

TnI in striated muscles is a key component of the ternary troponin complex, where it, in concert with the Ca2+-binding subunit troponin C (TnC) and the tropomyosin-binding subunit troponin T, Ca2+ dependently switches on and off the contractile machinery. This critical involvement in the regulation of thin-filament activation raises the possibility that proteolysis of even a small fraction of TnI may suffice to cause the contractile dysfunction typical of stunned myocardium (13). We (23) generated a transgenic (TG) animal model in which mice cardiac specifically expressed TnI1-193 at a fraction of total TnI comparable with that found in ischemic-reperfused rat hearts and reported that the myocardium of TG mice at baseline exhibits contractile dysfunction. In that initial report, the response of tension development during twitches to different Ca2+ concentrations was not investigated nor was signal transduction probed. Furthermore, precise analysis of the Ca2+ sensitivity of contraction was impaired by the low overall Ca2+ sensitivity of the intact mouse myocardium.

The present work adds to our recent study by demonstrating that, despite impaired E-C coupling, isolated intact trabeculae from TG mice maintain a contractile reserve that can be recruited by positive inotropic interventions. We also verify that, during twitches, TG mouse trabeculae exhibit both reduced Ca2+ sensitivity and Ca2+ responsiveness, thereby recapitulating key features of genuine stunned myocardium. A preliminary report has been previously published (see Ref. 18).


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Transgenic mouse model. Transgenic mice with cardiac expression of the equivalent of the major proteolytic product of TnI (TnI1-193) in stunned myocardium were produced as described (23). Transgene status was assessed by PCR from genomic DNA prepared from tail clips using a Gentra puregene kit and transgene-specific oligonucleotides. Non-TG control mice were either littermates of TG mice or were obtained from the same parental strain (C57BL/6).

Mouse intact muscle preparation. All experimental procedures were approved by the Johns Hopkins University Animal Care and Use Committee and were carried out essentially as described (14). Adult mice (age 3-8 mo) of either gender were euthanized by intraperitoneal injection of pentobarbitol sodium (~7.5-15 mg), and their hearts were excised. Intact trabeculae or thin papillary muscles were isolated from the right ventricles and mounted in a superfusion bath between a force transducer (type AE 801, SensoNor; Horten, Norway) and a rigid hook connected to a micromanipulator for length adjustment. Thin unbranched preparations that were suitable for experiments were found in ~20% of mouse hearts. The muscles were superfused at 10 ml/min with a modified Krebs-Henseleit solution equilibrated with 95% O2-5% CO2, which contained (in mM): 142 Na+, 5 K+, 1.2 Mg2+, 1.0 Ca2+, 127 Cl-, 2 PO<UP><SUB>4</SUB><SUP>3−</SUP></UP>, 1.2 SO<UP><SUB>4</SUB><SUP>2−</SUP></UP>, 20 HCO<UP><SUB>3</SUB><SUP>−</SUP></UP>, and 10 glucose; pH 7.37-7.43. The preparations were excited by bipolar electrical field stimulation, with an amplitude of 8-15 V and a pulse width of 5 ms (Grass SD9 stimulator, Grass Instruments; Quincy, MA). After equilibration, muscles were stretched to the length at which the amplitude of developed twitch tension was maximal, corresponding to a sarcomere length of 2.1-2.2 µm (14). Tetanic contractions were elicited by stimulating the preparations at 10 Hz in the presence of 5 µM ryanodine at various extracellular Ca2+ concentrations ([Ca2+]o; 0.5-20.0 mM) to achieve an equilibrium between the intracellular free Ca2+ concentration ([Ca2+]i) and myofilament activation.

Measurement of [Ca2+]i using fura 2. Fura 2 pentapotassium salt (Molecular Probes; Eugene, OR) was microinjected iontophoretically into two to four cells and allowed to spread evenly throughout the entire preparation via gap junctions (2). Fura 2 fluorescence was excited at 340 and 380 nm, and the emitted light was collected at 510 nm by a photomultiplier tube (R2693, Hamamatsu; Bridgewater, NJ). The light signal was filtered at 100 Hz, collected by an analog-to-digital converter, and stored on a computer for later analysis. The autofluorescence of the muscle was subtracted from the raw fluorescence data, and [Ca2+]i was calculated using the following equation (15): [Ca2+]i = K<UP><SUB>d</SUB><SUP>′:</SUP></UP>(R - Rmin)/(Rmax - R), where R is the observed fluorescence ratio (340/380 nm), K<UP><SUB>d</SUB><SUP>′</SUP></UP> is the apparent dissociation constant of fura 2, Rmax is the fluorescence ratio (340/380 nm) at saturating [Ca2+], and Rmin is the ratio (340/380 nm) at 0 [Ca2+]. Values for K<UP><SUB>d</SUB><SUP>′</SUP></UP>, Rmax, and Rmin were obtained during in vivo calibration experiments on sentinel mouse muscles (14). All experiments were carried out at room temperature (22-23°C), which is an established procedure to circumvent the rapid loss of fura 2 from intact preparations that regularly occurs at higher temperatures (20). Accordingly, when measuring twitch contractions, we reduced the stimulation rate to 0.5 Hz to take into consideration the slowing of Ca2+ cycling processes that is associated with lower than physiological temperature.

Myofibrillar ATPase activity measurement. Myofibrils were prepared as described (24) with careful attention paid to the use of protease inhibitors. Assays were performed with the use of incubation conditions established by varying the total concentration of metals, salts, and ligands, maintaining ionic strength using the stability constants compiled by Fabiato (9), and were performed at pH 7.0 with 50 mM imidazole, 50 mM KCl, and 2 mM MgATP. Inorganic phosphate liberation was measured using a microtiter plate version of the standard assay as described by Rarick et al. (25), and the ATPase activity was calculated in nanomoles of inorganic phosphate liberated per milligram of myofibrillar protein per minute.

beta -Adrenergic stimulation. l-Isoproterenol (Sigma; St. Louis, MO) was added to the superfusate from a 1 mM stock solution in distilled H2O to a final concentration of 300 nM.

Analytical methods. Measured force was converted into tension by normalization with respect to the cross-sectional area of each muscle. To characterize the steady-state tension-[Ca2+]i relationship, tension and [Ca2+]i data obtained from each muscle during tetanic contractions were fitted to a Hill equation as follows: FX - Fmin = (Fmax - Fmin)[CaX]<SUP><IT>n</IT><SUB>H</SUB></SUP>/ [(Ca50)<SUP><IT>n</IT><SUB>H</SUB></SUP> + [CaX]<SUP><IT>n</IT><SUB>H</SUB></SUP>], where FX is actual tension, Fmin is resting tension, Fmax is maximal Ca2+-activated tension, [CaX] is actual [Ca2+]i, Ca50 is the [Ca2+]i required for development of half-maximal tension, and nH is the Hill coefficient. To provide an additional estimate of the Ca2+ sensitivity of the preparations, tension was plotted versus [Ca2+]i during twitches, and the descending limb of these phase-plane loops during tension decline was fitted to the Hill equation to calculate Ca50 values for individual twitches. Statistical significance of data was analyzed using a multivariate ANOVA to independently assess the effects of [Ca2+]o and groups. The effects of isoproterenol were analyzed using Student's paired t-test. P < 0.05 was considered statistically significant. Pooled data are expressed as means ± SE.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Effect of [Ca2+]o on Ca2+ transients and twitch tension. We simultaneously examined Ca2+ cycling and tension development during twitches of TG and non-TG mouse intact right ventricular trabeculae at various [Ca2+]o. We carried out the experiments in a blinded fashion such that the investigator did not know the group identity of a mouse until after analysis of the data. Figure 1 shows the time course of [Ca2+]i and tension of representative non-TG and TG TnI1-193 preparations at 2.0 and 3.0 mM [Ca2+]o. The [Ca2+]i transients were very similar, whereas twitch tension was greatly reduced in the TG preparation. Considering the generally low responsiveness of the isolated intact mouse myocardium to external Ca2+ (14), we explored whether this contractile dysfunction can be overcome by high [Ca2+]o or is preserved over a broader range of inotropic intervention by raising [Ca2+]o incrementally from 1.0 to 6.0 mM. This intervention resulted in a stepwise increase in peak systolic [Ca2+]i in the non-TG control group with a quasilinear relationship (Fig. 2A), whereas diastolic [Ca2+]i remained unaltered, indicating that diastolic Ca2+ overload did not occur. The elevation in peak [Ca2+]i was paralleled by an increase in developed twitch tension (i.e., peak systolic tension minus resting tension) from 2.8 ± 1.5 to 40.3 ± 5.8 mN/mm2 at 1.0 and 6.0 mM [Ca2+]o, respectively (n = 6; Fig. 2B).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   Comparison of intracellular free Ca2+ concentration ([Ca2+]i) transients (top) and twitch tension (bottom) in a nontransgenic (non-TG) control and TG troponin I (TnI) fragment (TnI1-193) preparation. Original records of representative preparations from non-TG control (left) and TG TnI1-193 (right) hearts at 2.0 and 3.0 mM extracellular Ca2+ concentration ([Ca2+]o). Whereas the [Ca2+]i transients were similar, twitch tension was greatly reduced in the TG preparation.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 2.   Excitation-contraction coupling in TG muscles and non-TG controls. A: dependence of peak systolic (squares) and diastolic (circles) [Ca2+]i on [Ca2+]o. B: dependence of developed twitch tension on [Ca2+]o. Filled symbols, non-TG controls; open symbols, TG TnI1-193 preparations. Despite similar peak systolic [Ca2+]i values, twitch tension in TG muscles was significantly reduced compared with non-TG controls.

Muscles from TG hearts also showed an increase in peak systolic [Ca2+]i upon raising [Ca2+]o, with a relationship almost identical to that observed in control muscles (Fig. 2A). No difference in diastolic [Ca2+]i was apparent between groups. Developed tension in TG muscles likewise increased with [Ca2+]o, revealing a considerable contractile reserve. However, in marked contrast to [Ca2+]i, over the entire tested range of [Ca2+]o, developed twitch tension was reduced by a factor of ~0.5 compared with non-TG controls, ranging from 0.8 ± 0.7 to 21.3 ± 2.8 mN/mm2 at 1.0 and 6.0 mM [Ca2+]o, respectively (n = 6). Tension development was highly significantly different between the two groups (P < 0.0001; Fig. 2B).

Characterization of the tension-[Ca2+]i relationship. We measured isometric tension and [Ca2+]i during the plateau phase of tetani elicited by 10-Hz stimulation in the presence of ryanodine to characterize the steady-state tension-[Ca2+]i relationship (Fig. 3, A and B; data partially included in Ref. 23). Non-TG control muscles attained a substantially higher maximum Ca2+-activated tension than TG muscles (48.14 ± 7.23, n = 5, vs. 28.70 ± 0.88 mN/mm2, n = 4, P = 0.0036). Resting tensions and Hill coefficients were similar in both groups. From Fig. 3B, which illustrates the normalized tension-[Ca2+]i relationships, it is obvious that the midpoint of the relation was shifted toward higher [Ca2+]i in TG muscles by ~340 nM, but this effect was not significant. However, a problematic feature of these steady-state tension-[Ca2+]i relationships is the low Ca2+ sensitivity of mouse intact preparations compared, e.g., with the rat myocardium. The Ca50 for isometric tension falls in a range (~1.3-1.6 µM) that is relatively far off the Kd of fura 2 for Ca2+ (224 nM; see Ref. 15) such that subtle changes in fluorescence properties reflect large differences in [Ca2+]. Therefore, to obtain a more accurate estimate for the Ca2+ sensitivity of the preparations, we analyzed the relationship of tension and [Ca2+]i during the relaxation phase of regular twitches. In Fig. 4, A and B, developed tension is plotted versus [Ca2+]i during twitches at three different [Ca2+]o for representative non-TG and TG1-193 muscles (phase-plane loops). The descending limb of these loops, due to the phase lag between [Ca2+]i and tension, is shifted toward lower [Ca2+]i compared with the steady-state tension-[Ca2+]i relationship of the same muscle (1) and therefore falls in a range of [Ca2+]i that is more accurately reflected by the fura 2 fluorescence properties. In TG TnI1-193 muscles, half-maximal tension during relaxation was attained at significantly higher [Ca2+]i than in non-TG control muscles (0.53 ± 0.04 vs. 0.42 ± 0.03 µM, respectively, P = 0.035; Fig. 4C), indicating reduced Ca2+ sensitivity.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   Steady-state tension-[Ca2+]i relationship. A: absolute values of tension during tetani. B: tension values normalized to the maximum tension under the respective condition. Straight line and , non-TG controls; dashed line and , TG TnI1-193 preparations. Maximum Ca2+-activated tension is significantly reduced in TG preparations. After normalization, a rightward shift of the relationship in TG preparations became apparent, which was, however, not significant.



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   Tension-[Ca2+]i relationship derived from twitch data. A: phase-plane loops of a representative non-TG control preparation at 3.0, 4.0, and 6.0 mM [Ca2+]o. B: phase-plane loops of a representative TG TnI1-193 preparation at 4.0, 5.0, and 7.0 mM [Ca2+]o. C: comparison of [Ca2+]i required for development of half-maximal tension (Ca50) values during the relaxation phase of twitches. Hill curves have been fitted to the descending limbs of the loops in A and B. During relaxation, 50% of peak tension was reached at significantly higher [Ca2+]i in TG TnI1-193 preparations compared with control (Con), indicating Ca2+ desensitization.

Myofibrillar ATPase activity. We measured the ATPase activity of myofibrils extracted from non-TG control and TG TnI1-193 mouse hearts (Fig. 5). The Ca2+-independent basal myofibrillar ATPase activity was similar in both groups. Non-TG control myofibrils exhibited a maximum Ca2+-activated ATPase activity of 193 ± 9 nmol · mg-1 · min-1 (n = 8). In TG myofibrils, this ATPase activity was reduced by 38% to 119 ± 5 nmol · mg-1 · min-1 (n = 7, P = 0.002). This reduction closely corresponds to the 40% lower maximum Ca2+-activated tension observed in intact muscle preparations.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 5.   Myofibrillar ATPase activity. Maximum Ca2+-activated myofibrillar ATPase activity was reduced by 38% in TG TnI1-193 compared with non-TG control preparations, which is equivalent to the reduction in maximum Ca2+-activated tension observed in intact TG TnI1-193 muscle preparations.

Inotropic response to beta -adrenergic receptor stimulation. A typical feature of stunned myocardium is its maintained contractile reserve when stimulated with positive inotropic agents, e.g., catecholamines (3, 8). We therefore treated non-TG control and TG muscles with 300 nM l-isoproterenol to examine whether this property is preserved in mouse muscles expressing TnI1-193. In non-TG control muscles, isoproterenol induced a clear positive inotropic response: developed twitch tension at [Ca2+]o of 1.0, 2.0, and 3.0 mM was markedly and significantly increased 15-, 6-, and 3.2-fold, respectively, compared with twitch contractions at the same [Ca2+]o in the absence of isoproterenol (Fig. 6B). At 3.0 mM [Ca2+]o in the presence of isoproterenol, twitch tension approached a maximal level (56.66 ± 18.16 mN/mm2), which was not significantly different from either maximum Ca2+-activated tension in tetanic contractions or the greatest twitch tension attained at 6.0 mM [Ca2+]o in the absence of isoproterenol (48.11 ± 7.23 and 44.48 ± 6.44 mN/mm2, respectively). Increasing [Ca2+]o to values >3.0 mM in the presence of isoproterenol invariably caused diastolic Ca2+ overload and irregular spontaneous contractions. The elevation of twitch tension was associated with a pronounced increase in peak systolic [Ca2+]i (Fig. 6A), consistent with the known pharmacological property of beta -adrenergic receptor agonists to exert their positive inotropic action by increasing calcium availability.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of isoproterenol on [Ca2+]i transients and twitch tension. A: peak systolic [Ca2+]i. B: developed twitch tension. Left: Non-TG controls (filled symbols); right: TG1-193 preparations (open symbols). Squares, no isoproterenol; circles, 300 nM isoproterenol. Insets: time courses of [Ca2+]i transients (A) and twitch tension (B), respectively. Gray trace, no isoproterenol; solid trace, 300 nM isoproterenol. *Significant difference between untreated and isoproterenol-treated condition. In both groups, isoproterenol recruited a contractile reserve by increasing peak systolic [Ca2+]i. Developed twitch tension in TG TnI1-193 preparations remained reduced compared with non-TG controls.

In TG TnI1-193 muscles, isoproterenol elicited a response similar to that seen in non-TG control muscles (Fig. 6, A and B): at 1.0, 2.0, and 3.0 mM [Ca2+]o, developed twitch tension in the presence of isoproterenol was significantly increased 10-, 5.5-, and 2.3-fold, respectively, compared with twitches in the absence of isoproterenol. The relative increase in twitch tension caused by isoproterenol was comparable in non-TG control and TG muscles. Also, in the TG group, developed tension approached a steady-state level at 3.0 mM [Ca2+]o (24.32 ± 4.10 mN/mm2), which was not significantly different from the maximum Ca2+-activated tension in tetanic contractions or maximum twitch tension attained at 6.0 mM [Ca2+]o in the absence of isoproterenol (28.70 ± 0.88 and 20.52 ± 7.07 mN/mm2, respectively). As in non-TG control muscles, raising [Ca2+]o to values exceeding 3.0 mM was accompanied by Ca2+ overload and spontaneous contractile activity of the muscles. Also in TG muscles, the isoproterenol-induced enhancement of developed tension was associated with a marked increase in peak systolic [Ca2+]i, similar to non-TG control muscles. Isoproterenol in the TG group did not enhance twitch tension to the values attained when non-TG muscles were treated with the drug. Rather, the reduction by a factor of ~0.5, as observed in the absence of isoproterenol, was maintained in its presence. Notably, however, twitch tension in isoproterenol-treated TG TnI1-193 muscles was at least not different, and at 1.0 mM [Ca2+]o even significantly higher, than that exerted by untreated non-TG control muscles at the same [Ca2+]o (Fig. 6B).

Kinetic effects of isoproterenol on twitch tension and Ca2+ transients. We compared twitch contractions at 3.0 mM [Ca2+]o before and after beta -adrenergic receptor stimulation. Figure 6, A and B (insets), shows normalized records of [Ca2+]i and tension versus time from representative muscles in each group in the absence and presence of isoproterenol. Isoproterenol exerted a similar lusitropic action in both non-TG control and TG muscles (Table 1). The time to peak systolic [Ca2+]i was not significantly altered. In contrast, the time from peak to half-decay of [Ca2+]i, the time to peak tension, and the time from peak tension to half relaxation were significantly reduced by isoproterenol in both groups to a similar extent.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Kinetic effects of isoproterenol


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The present study extends our previous findings (23) in several major ways. Here, we show that intracellular Ca2+ transients, sampled over a wide range of [Ca2+]o, are indistinguishable in trabeculae from TG mouse hearts and control muscles, consistent with unimpaired Ca2+ cycling. In marked contrast, twitch tension in TG muscles is greatly decreased, indicating uncoupling of excitation and contraction. The contractile dysfunction in TG TnI1-193 preparations is due to both a reduced overall tension-generating capacity of TG muscles, reflected by the lower maximum Ca2+-activated tension (which is paralleled by an equivalent reduction in maximum Ca2+-activated myofibrillar ATPase activity), and a decrease in Ca2+ sensitivity, reflected by the increase in Ca50 during the relaxation phase of twitches. The proportionately similar inotropic responses to increases in [Ca2+]o and to isoproterenol reveal that muscles from both groups have a sizable contractile reserve that can be recruited by positive inotropic intervention and that the beta -adrenergic signaling cascade is intact. In both the TG TnI1-193 and non-TG control myocardium, the maximum twitch tension attainable is limited by the maximum Ca2+-activated tension, as found in tetanic contractions at saturating [Ca2+]o.

These features closely recapitulate the functional characteristics found in isolated trabeculae from rat hearts subjected to 20-min ischemia/20-min reperfusion (12) and also reproduce a well-established property of stunned myocardium in that the contractile dysfunction can partially be overcome by stimulation with positive inotropic agents (3, 8). This phenotype also finds its equivalent in the more physiological model of regional low-flow ischemia-reperfusion in pigs, where likewise maximum calcium-stimulated contractility was greatly impaired, whereas a reduction in calcium sensitivity appeared to be less prominent (16). Therefore, the presence of even a low amount of TnI1-193 in the absence of any additional damage suffices to produce the defective E-C coupling with a maintained beta -adrenergic signaling cascade typical of stunning. These findings, as well as the impairment in hemodynamic function in these mice in vivo (23), strongly support the putative causal role of TnI degradation in the pathogenesis of myocardial stunning. Moreover, because in this TG mouse model the TnI fragment 1-193 is generated independent of proteolysis of the parent protein, the 17-residue COOH-terminal fragment formed as a byproduct of TnI proteolysis in genuine stunned myocardium is not necessary to induce the "stunned" phenotype.

In this and also our previous study (23), the comparative analysis of the steady-state tension-[Ca2+]i relationships did not allow us to make a conclusive statement about differences in the Ca2+ sensitivity of TG TnI1-193 and non-TG control preparations. This was due to the generally low Ca2+ sensitivity of tension observed in the mouse intact myocardium (14) in which Ca50 values fall in a range where [Ca2+]i calculated from fura 2 fluorescence data shows considerable dispersion. Because of this inaccuracy, to confirm a statistically significant difference of Ca50 values between groups would require experimental numbers that are both impractical and ethically questionable to achieve, given the low frequency of suitable preparations in mouse hearts and considering that reliable information on the Ca2+ sensitivity can be extracted from twitch data using the alternative method we established here. During the relaxation phase of a twitch, myofilament activation (i.e., tension) and [Ca2+]i exhibit a sigmoidal relationship. Because of the phase lag between [Ca2+]i and tension during a twitch, this relationship is shifted toward lower [Ca2+]i compared with steady-state conditions during tetani elicited in the presence of ryanodine, to a range in which fura 2 fluorescence properties allow for calculation of [Ca2+]i with greater accuracy. In the twitch tension-[Ca2+]i plots (phase-plane "loops"), a Hill equation can be fitted to the descending limb and a Ca50 value can be calculated that represents the [Ca2+]i at which active tension has declined to 50% of the peak value.

To calculate Ca50 from the steady-state tension-[Ca2+]i relationship is an accepted procedure to analyze the Ca2+ sensitivity of intact cardiac preparations, because during the plateau of tetanic contractions a well-characterized and highly reproducible equilibrium exists between [Ca2+]i and the level of myofilament activation. This equilibrium, however, is generated under unphysiological conditions involving 10-Hz stimulation and disruption of sarcoplasmic reticulum function using ryanodine. In contrast, the experimental conditions during twitches are more physiological. The leftward shift of the descending limb compared with the steady-state tension-[Ca2+]i relationship indicates that relaxation in cardiac muscle is not limited by the decay rate of the [Ca2+]i transient but rather by the myofilaments themselves (1). Thus the Ca50 value calculated from twitch relaxation truly represents properties intrinsic to the myofilaments and therefore can be used to compare the Ca2+ sensitivities of different groups. It is clear, however, that Ca50 values calculated from twitch relaxation data must not be compared with Ca50 values calculated from steady-state data. Because of damaged-end compliance (28) and the length dependence of Ca2+ sensitivity, sarcomere shortening in the central part of the preparation may theoretically decrease the overall Ca2+ sensitivity of a preparation. Additionally, central sarcomere shortening has been observed to result in an increase of the peak of the Ca2+ transient (17). Both these effects would be expected to be more pronounced in the group of preparations contracting more strongly, i.e., in non-TG control muscles. If anything, this effect will tend to underestimate the difference in Ca2+ sensitivity between control and TG preparations, as detected in this study, and therefore does not affect the conclusions drawn regarding the effect of TnI1-193 expression on Ca2+ sensitivity.

In our previous study (23), impedance catheter measurements revealed that beta -adrenergic receptor stimulation increased the maximal rate of pressure development (dP/dtmax) in both TG and non-TG mice. The maximal rate of decay of pressure (dP/dtmin), however, was not affected in vivo by isoproterenol treatment (23). If the beta -adrenergic pathway is intact, cAMP-dependent phosphorylation of phospholamban and TnI is expected to accelerate relaxation in cardiac muscle. We therefore analyzed the effects of isoproterenol on the kinetics of tension and [Ca2+]i transient during twitches of trabeculae isolated from their environment. Our data confirm that, in isolated muscle preparations from both TG TnI1-193 and non-TG control mice, isoproterenol treatment significantly enhanced the speed of contraction and relaxation, consistent with the beta -adrenergic cascade being intact in our transgenic model. The lack of effect of isoproterenol on -dP/dtmin in vivo may be explained by prior sympathetic activation due to anesthesia of the animals or by additional effects on the systemic vascular resistance, which can be excluded in the isolated cardiac muscle preparation.

The mechanism by which TnI1-193 impairs contractility is unknown. Degradation of a certain amount of intact TnI could result in partial "loss of function" of the full-length protein. Alternatively, a "gain of function" of the degraded form of TnI could occur, exposing regulatory properties different from those of the parent protein. A complete loss of function of a fraction of TnI most likely would result in failure of the myocardium to relax fully, analogous to myocardium from which TnI has been partially extracted, e.g., using vanadate (27). This is not likely to be the case in TG preparations, because we did not observe any elevation in resting tension. The concept of altered regulatory properties of the deletion mutant is supported by Rarick et al. (26), who demonstrated that recombinant cTnI1-188, which is missing only six more residues than the transgenically generated cTnI1-193 fragment used in our study, displayed impaired ability to fully inhibit myofibrillar ATPase activity in the absence of Ca2+ and to fully activate myofibrillar ATPase activity at saturating [Ca2+], whereas cTnI1-199 behaved essentially as the wild-type protein. A recent study (10) mapping cardiac TnI-TnC interactions with synthetic peptides identified an interaction between TnI191-210 and TnC (10). Furthermore, two point mutations located within this region, Gly203Ser and Lys206Gln, are associated with familial hypertrophic cardiomyopathy (6), underlining the possible functional relevance of loss of this segment. Whether or not the regulatory properties of TnI1-193 are qualitatively or quantitatively different from those of the parent protein cannot be resolved on intact isolated muscle preparations of this TG mouse model. Our observation that maximum Ca2+-activated myofibrillar ATPase activity in TG preparations is reduced to a similar extent as maximum Ca2+-activated tension in intact trabeculae indicates that the effect of TnI truncation on actomyosin interaction does not depend on the strain on the cross-bridges, because a suspension of myofibrils in solution bears no load. Further studies involving the biochemical characterization of purified recombinant troponin subunits are required to clarify this point.

An important question remains as to whether TnI degradation is necessary for the development of stunning, because several studies (21, 29) in larger animal models failed to demonstrate TnI degradation in stunned myocardium. It has, however, been pointed out that to reliably exclude the presence of TnI degradation products by Western blot analysis requires probing of tissue samples with a variety of antibodies directed against different epitopes on TnI (11), and, importantly, TnI degradation has been observed in myocardial biopsies of human ischemic heart disease patients (23).

In summary, we present evidence confirming that TnI1-193 is capable of producing the stunned phenotype in the absence of any additional ischemia-reperfusion-induced damage, supporting the hypothesis that stunning is caused by proteolytic degradation of TnI. The preservation of upstream inotropic responsiveness implies that calcium and beta -adrenergic signaling remain intact in the TG mice, as they do in genuine stunned myocardium.


    ACKNOWLEDGEMENTS

We thank J. Robinson for technical assistance and P. M. L. Janssen for help with analyzing the ATPase data.


    FOOTNOTES

This work was supported by Deutsche Forschungsgemeinschaft Grant KO 1873/1-1 (to H. Kögler), National Heart, Lung, and Blood Institute Grants F32 HL-10401 (to D. G. Soergel), R01 HL-63038 (to A. M. Murphy), and R01 HL-44065 (to E. Marbán), an American Heart Association grant-in-aid (to A. M. Murphy), and by the Michel Mirowski M.D. Professorship of Cardiology (to E. Marbán).

Address for reprint requests and other correspondence: E. Marbán, Institute of Molecular Cardiobiology, Johns Hopkins Univ., 844 Ross Bldg., 720 Rutland Ave., Baltimore, MD 21205 (E-mail: marban{at}jhmi.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 6 November 2000; accepted in final form 31 January 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Backx, PH, Gao WD, Azan-Backx MD, and Marbán E. The relationship between contractile force and intracellular [Ca2+] in intact rat cardiac trabeculae. J Gen Physiol 105: 1-19, 1995[Abstract/Free Full Text].

2.   Backx, PH, and Ter Keurs HEDJ Fluorescent properties of rat cardiac trabeculae microinjected with fura 2 salt. Am J Physiol Heart Circ Physiol 264: H1098-H1110, 1993[Abstract/Free Full Text].

3.   Becker, LC, Levine JH, DiPaula AF, Guarnieri T, and Aversano T. Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation. J Am Coll Cardiol 7: 580-589, 1986[Abstract].

4.   Bolli, R. Myocardial "stunning" in man. Circulation 86: 1671-1691, 1992[Free Full Text].

5.   Bolli, R, and Marbán E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79: 609-634, 1999[Abstract/Free Full Text].

6.   Bonne, G, Carrier L, Richard P, Hainque B, and Schwartz K. Familial hypertrophic cardiomyopathy. Circ Res 83: 580-593, 1998[Abstract/Free Full Text].

7.   Braunwald, E, and Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66: 1146-1149, 1982[Abstract/Free Full Text].

8.   Ellis, SG, Wynne J, Braunwald E, Henschke CI, Sandor T, and Kloner RA. Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation. Am Heart J 107: 13-19, 1984[Web of Science][Medline].

9.   Fabiato, A. Myoplasmic free calcium concentration reached during the twitch of an intact isolated cardiac cell and during calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned cardiac cell from the adult rat or rabbit ventricle. J Gen Physiol 78: 457-497, 1981[Abstract/Free Full Text].

10.   Ferrières, G, Pugnière M, Mani JC, Villard S, Laprade M, Doutre P, Pau B, and Granier C. Systemic mapping of regions of human cardiac troponin I involved in binding to cardiac troponin C: N- and C-terminal low affinity contributing regions. FEBS Lett 479: 99-105, 2000[Web of Science][Medline].

11.   Foster, DB, and Van Eyk JE. In search of the proteins that cause myocardial stunning. Circ Res 85: 470-472, 1999[Free Full Text].

12.   Gao, WD, Atar D, Backx PH, and Marbán E. Relationship between intracellular calcium and contractile force in stunned myocardium. Circ Res 76: 1036-1048, 1995[Abstract/Free Full Text].

13.   Gao, WD, Atar D, Liu Y, Pérez NG, Murphy AM, and Marbán E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res 80: 393-399, 1997.

14.   Gao, WD, Pérez NG, and Marbán E. Calcium cycling and contractile activation in intact mouse cardiac muscle. J Physiol 507: 175-184, 1998[Abstract/Free Full Text].

15.   Grynkiewicz, G, Poenie M, and Tsien TY. A new generation of Ca2+ indicators with greatly improved fluorescent properties. J Biol Chem 260: 3440-3450, 1985[Abstract/Free Full Text].

16.   Heusch, G, Rose J, Skyschally A, Post H, and Schulz R. Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ porcine heart. Circulation 93: 1556-1566, 1996[Abstract/Free Full Text].

17.   Janssen, PML, and de Tombe PP. Uncontrolled sarcomere length shortening increases the intracellular Ca2+ transient in rat cardiac trabeculae. Am J Physiol Heart Circ Physiol 272: H1892-H1897, 1997[Abstract/Free Full Text].

18.   Kögler, H, Murphy AM, and Marbán E. Excitation-contraction coupling in a transgenic mouse model of stunned myocardium (Abstract). Circulation 100, SupplI: I-766, 1999.

19.   Kusuoka, H, Koretsune Y, Chacko VP, Weisfeldt ML, and Marbán E. Excitation-contraction coupling in postischemic myocardium: does failure of activator Ca2+ transients underlie stunning? Circ Res 66: 1268-1276, 1990[Abstract/Free Full Text].

20.   Layland, J, and Kentish JC. Positive force- and [Ca2+]i-frequency relationships in rat ventricular trabeculae at physiological frequencies. Am J Physiol Heart Circ Physiol 276: H9-H18, 1999[Abstract/Free Full Text].

21.   Matejovicova, M, Kaplan P, Mubagwa K, Raeymaekers L, Pongo E, and Flameng W. Phosphorylation by protein kinases A and C of myofibrillar proteins in rabbit stunned and non-stunned myocardium. J Mol Cell Cardiol 29: 3189-3202, 1997[Web of Science][Medline].

22.   McDonough, JL, Arrell DK, and Van Eyk JE. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res 84: 9-20, 1999[Abstract/Free Full Text].

23.   Murphy, AM, Kögler H, Georgakopoulos D, McDonough JL, Kass DA, Van Eyk JE, and Marbán E. Transgenic mouse model of stunned myocardium. Science 287: 488-491, 2000[Abstract/Free Full Text].

24.   Murphy, AM, and Solaro RJ. Developmental difference in the stimulation of cardiac myofibrillar Mg2(+)-ATPase activity by calmidazolium. Pediatr Res 28: 46-49, 1990[Web of Science][Medline].

25.   Rarick, HM, Opgenorth TJ, von Geldern TW, Wu-Wong JR, and Solaro RJ. An essential myosin light chain peptide induces supramaximal stimulation of cardiac myofibrillar ATPase activity. J Biol Chem 271: 27039-27043, 1996[Abstract/Free Full Text].

26.  Rarick HM, Tu XH, Solaro RJ, and Martin AF. The C terminus of cardiac troponin I is essential for full inhibitory activity and Ca2+ sensitivity of rat myofibrils. J Biol Chem 272: 26887-26892.

27.   Strauss, JD, Zeugner C, Van Eyk JE, Bletz C, Troschka M, and Rüegg JC. Troponin replacement in permeabilized cardiac muscle. Reversible extraction of troponin I by incubation with vanadate. FEBS Lett 310: 229-234, 1992[Web of Science][Medline].

28.   Ter Keurs, HEDJ, Rijnsburger WH, van Heuningen R, and Nagelsmit MJ. Tension development and sarcomere length in rat cardiac trabeculae: evidence of length-dependent activation. Circ Res 46: 703-714, 1980[Free Full Text].

29.   Thomas, SA, Fallavollita JA, Lee TC, Feng J, and Canty FM. Absence of troponin I degradation or altered sarcoplasmic reticulum uptake protein expression after reversible ischemia in swine. Circ Res 85: 446-456, 1999[Abstract/Free Full Text].

30.   Yoshida, K, Inui M, Harada K, Saido TC, Sorimachi Y, Ishihara T, Kawashima S, and Sobue K. Reperfusion of rat heart after brief ischemia induces proteolysis of calspectrin (non-erythroid spectrin or fodrin) by calpain. Circ Res 77: 603-610, 1995[Abstract/Free Full Text].

31.   Yoshida, K, Yamasaki Y, and Kawashima S. Calpain activity alters in rat myocardial subfractions after ischemia or reperfusion. Biochim Biophys Acta 1182: 215-220, 1993[Medline].


Am J Physiol Heart Circ Physiol 280(6):H2623-H2630
0363-6135/01 $5.00 Copyright © 2001 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Liu, J. Du, C. Zhang, J. W. Walker, and X. Huang
Progressive troponin I loss impairs cardiac relaxation and causes heart failure in mice
Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1273 - H1281.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. C. Bilchick, J. G. Duncan, R. Ravi, E. Takimoto, H. C. Champion, W. D. Gao, L. B. Stull, D. A. Kass, and A. M. Murphy
Heart failure-associated alterations in troponin I phosphorylation impair ventricular relaxation-afterload and force-frequency responses and systolic function
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H318 - H325.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. G. Sirenko, J. D. Potter, and B. C. Knollmann
Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts - role of myofilament Ca2+ sensitivity increase
J. Physiol., August 15, 2006; 575(1): 201 - 213.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. D. Varian, S. Raman, and P. M. L. Janssen
Measurement of myofilament calcium sensitivity at physiological temperature in intact cardiac trabeculae
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2092 - H2097.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F. C. Chen and O. Ogut
Decline of contractility during ischemia-reperfusion injury: actin glutathionylation and its effect on allosteric interaction with tropomyosin
Am J Physiol Cell Physiol, March 1, 2006; 290(3): C719 - C727.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. G. Duncan, R. Ravi, L. B. Stull, and A. M. Murphy
Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1512 - H1518.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. B. Stull, M. K. Leppo, L. Szweda, W. D. Gao, and E. Marban
Chronic Treatment With Allopurinol Boosts Survival and Cardiac Contractility in Murine Postischemic Cardiomyopathy
Circ. Res., November 12, 2004; 95(10): 1005 - 1011.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. G. Soergel, D. Georgakopoulos, L. B. Stull, D. A. Kass, and A. M. Murphy
Augmented systolic response to the calcium sensitizer EMD-57033 in a transgenic model with troponin I truncation
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1785 - H1792.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. B. Foster, T. Noguchi, P. VanBuren, A. M. Murphy, and J. E. Van Eyk
C-Terminal Truncation of Cardiac Troponin I Causes Divergent Effects on ATPase and Force: Implications for the Pathophysiology of Myocardial Stunning
Circ. Res., November 14, 2003; 93(10): 917 - 924.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kögler, H.
Right arrow Articles by Marbán, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kögler, H.
Right arrow Articles by Marbán, E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online